Function_NN
of_IN
NF-kappa_NN
B\/Rel_NN
binding_NN
sites_NNS
in_IN
the_DT
major_JJ
histocompatibility_NN
complex_NN
class_NN
II_CD
invariant_JJ
chain_NN
promoter_NN
is_VBZ
dependent_JJ
on_IN
cell-specific_JJ
binding_NN
of_IN
different_JJ
NF-kappa_NN
B\/Rel_NN
subunits_NNS
._.

The_DT
promoter_NN
of_IN
the_DT
human_JJ
major_JJ
histocompatibility_NN
complex_NN
class_NN
II-associated_JJ
invariant-chain_JJ
gene_NN
-LRB-_-LRB-
Ii_NN
-RRB-_-RRB-
contains_VBZ
two_CD
NF-kappa_NN
B\/Rel_NN
binding_NN
sites_NNS
located_JJ
at_IN
-109_CD
to_TO
-118_CD
-LRB-_-LRB-
Ii_NN
kappa_NN
B-1_NN
-RRB-_-RRB-
and_CC
-163_CD
to_TO
-172_CD
-LRB-_-LRB-
Ii_NN
kappa_NN
B-2_NN
-RRB-_-RRB-
from_IN
the_DT
transcription_NN
start_NN
site_NN
._.

We_PRP
report_VBP
here_RB
that_IN
the_DT
differential_JJ
function_NN
of_IN
each_DT
of_IN
these_DT
NF-kappa_NN
B\/Rel_NN
sites_NNS
in_IN
several_JJ
distinct_JJ
cell_NN
types_NNS
depends_VBZ
on_IN
cell-specific_JJ
binding_NN
of_IN
NF-kappa_NN
B\/Rel_NN
transcription_NN
factors_NNS
._.

Ii_NN
kappa_NN
B-1_NN
is_VBZ
a_DT
positive_JJ
regulatory_JJ
element_NN
in_IN
B-cell_NN
lines_NNS
and_CC
in_IN
the_DT
Ii-expressing_JJ
T-cell_NN
line_NN
,_,
H9_NN
,_,
but_CC
acts_VBZ
as_IN
a_DT
negative_JJ
regulatory_JJ
element_NN
in_IN
myelomonocytic_JJ
and_CC
glia_NN
cell_NN
lines_NNS
._.

In_FW
vivo_FW
protein-DNA_JJ
contacts_NNS
are_VBP
detectable_JJ
at_IN
Ii_NN
kappa_NN
B-1_NN
in_IN
cell_NN
lines_NNS
in_IN
which_WDT
this_DT
site_NN
is_VBZ
functional_JJ
as_IN
either_CC
a_DT
positive_JJ
or_CC
negative_JJ
regulator_NN
._.

Electrophoretic_JJ
mobility_NN
supershift_NN
assays_NNS
determine_VBP
that_IN
members_NNS
of_IN
the_DT
NF-kappa_NN
B\/Rel_NN
family_NN
of_IN
transcription_NN
factors_NNS
can_MD
bind_VB
to_TO
this_DT
site_NN
in_FW
vitro_FW
and_CC
that_IN
DNA-binding_JJ
complexes_NNS
that_WDT
contain_VBP
p50_NN
,_,
p52_NN
,_,
p65_NN
,_,
and_CC
cRel_NN
correlate_VBP
with_IN
positive_JJ
regulation_NN
whereas_IN
the_DT
presence_NN
of_IN
p50_NN
correlates_VBZ
with_IN
negative_JJ
regulation_NN
._.

Ii_NN
kappa_NN
B-2_NN
is_VBZ
a_DT
site_NN
of_IN
positive_JJ
regulation_NN
in_IN
B-cell_NN
lines_NNS
and_CC
a_DT
site_NN
of_IN
negative_JJ
regulation_NN
in_IN
H9_NN
T_NN
cells_NNS
,_,
myelomonocytic_JJ
,_,
and_CC
glial_JJ
cell_NN
lines_NNS
._.

In_FW
vivo_FW
occupancy_NN
of_IN
this_DT
site_NN
is_VBZ
observed_VBN
only_RB
in_IN
the_DT
H9_NN
T-cell_NN
line_NN
._.

Again_RB
,_,
in_FW
vitro_FW
supershift_NN
studies_NNS
indicate_VBP
that_IN
the_DT
presence_NN
of_IN
p50_NN
,_,
p52_NN
,_,
p65_NN
,_,
and_CC
cRel_NN
correlates_VBZ
with_IN
positive_JJ
function_NN
whereas_IN
the_DT
presence_NN
of_IN
only_RB
p50_NN
and_CC
p52_NN
correlates_VBZ
with_IN
negative_JJ
function_NN
._.

This_DT
differential_JJ
binding_NN
of_IN
specific_JJ
NF-kappa_NN
B\/Rel_NN
subunits_NNS
is_VBZ
likely_JJ
to_TO
mediate_VB
the_DT
disparate_JJ
functions_NNS
of_IN
these_DT
two_CD
NF-kappa_NN
B\/Rel_NN
binding_NN
sites_NNS
._.

